Related references
Note: Only part of the references are listed.Myelodysplastic Syndromes with Bone Marrow Fibrosis : An Update
Akriti G. Jain et al.
ANNALS OF LABORATORY MEDICINE (2022)
TERT Rare Variants in Myeloid Neoplasia: Lack of Clinical Impact or Role as Risk Alleles
Carmelo Gurnari et al.
BLOOD (2021)
Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine-learning assisted morphometrics
Carina A. Rosenberg et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2021)
Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes
Aziz Nazha et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Integration Analysis of JAK2 or RUNX1 Mutation With Bone Marrow Blast Can Improve Risk Stratification in the Patients With Lower Risk Myelodysplastic Syndrome
Ying Fang et al.
FRONTIERS IN ONCOLOGY (2021)
A novel scoring system integrating molecular abnormalities with IPSS-R can improve the risk stratification in patients with MDS
Siyu Gu et al.
BMC CANCER (2021)
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes
Matteo Bersanelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored Treatments
Simona Pagliuca et al.
CANCERS (2021)
Have we reached a molecular era in myelodysplastic syndromes?
Maria Teresa Voso et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2021)
Alternative Splicing in Myeloid Malignancies
Carmelo Gurnari et al.
BIOMEDICINES (2021)
A geno-clinical decision model for the diagnosis of myelodysplastic syndromes
Nathan Radakovich et al.
BLOOD ADVANCES (2021)
A new convolutional neural network predictive model for the automatic recognition of hypogranulated neutrophils in myelodysplastic syndromes
Andrea Acevedo et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2021)
A machine learning approach to predicting risk of myelodysplastic syndrome
Ashwath Radhachandran et al.
LEUKEMIA RESEARCH (2021)
Machine Learning of Bone Marrow Histopathology Identifies Genetic and Clinical Determinants in Patients with MDS
Oscar E. Bruck et al.
BLOOD CANCER DISCOVERY (2021)
Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes
Yasunobu Nagata et al.
BLOOD (2020)
Implications ofTP53allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Elsa Bernard et al.
NATURE MEDICINE (2020)
Assessment of dysplasia in bone marrow smear with convolutional neural network
Jinichi Mori et al.
SCIENTIFIC REPORTS (2020)
Evaluation of different scoring systems and gene mutations for the prognosis of myelodysplastic syndrome (MDS) in Chinese population
Meng-yi Du et al.
JOURNAL OF CANCER (2020)
A Hematologist-Level Deep Learning Algorithm (BMSNet) for Assessing the Morphologies of Single Nuclear Balls in Bone Marrow Smears: Algorithm Development
Yi-Ying Wu et al.
JMIR MEDICAL INFORMATICS (2020)
Potential Liability for Physicians Using Artificial Intelligence
W. Nicholson Price et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
A novel automated image analysis system using deep convolutional neural networks can assist to differentiate MDS and AA
Konobu Kimura et al.
SCIENTIFIC REPORTS (2019)
BCOR and BCORL1 mutations in myelodysplastic syndromes (MDS): clonal architecture and impact on outcomes
Nour Abuhadra et al.
LEUKEMIA & LYMPHOMA (2019)
Digital twins to personalize medicine
Bergthor Bjornsson et al.
GENOME MEDICINE (2019)
Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population-based setting: a report from the Swedish MDS register
Daniel Moreno Berggren et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas
Jean E. Goasguen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Myelodysplastic syndromes current treatment algorithm 2018
David P. Steensma
BLOOD CANCER JOURNAL (2018)
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome
Hsin-An Hou et al.
BLOOD CANCER JOURNAL (2018)
Potential Biases in Machine Learning Algorithms Using Electronic Health Record Data
Milena A. Gianfrancesco et al.
JAMA INTERNAL MEDICINE (2018)
Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromes
Abdullah Mahmood Ali et al.
BLOOD ADVANCES (2018)
Patient-Reported Outcomes Enhance the Survival Prediction of Traditional Disease Risk Classifications: An International Study in Patients With Myelodysplastic Syndromes
Fabio Efficace et al.
CANCER (2018)
Training echo state networks for rotation-invariant bone marrow cell classification
Philipp Kainz et al.
NEURAL COMPUTING & APPLICATIONS (2017)
White blood cell differential count of maturation stages in bone marrow smear using dual-stage convolutional neural networks
Jin Woo Choi et al.
PLOS ONE (2017)
Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides
A. M. Zeidan et al.
LEUKEMIA (2016)
The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure
Aziz Nazha et al.
HAEMATOLOGICA (2016)
Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS)
Gregory A. Abel et al.
HAEMATOLOGICA (2016)
Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes
A. Nazha et al.
LEUKEMIA (2016)
The efficacy of current prognostic models in predicting outcome of patients with myelodysplastic syndromes at the time of hypomethylating agent failure
Aziz Nazha et al.
HAEMATOLOGICA (2016)
Prospective international validation of the Quality of Life in Myelodysplasia Scale (QUALMS)
Gregory A. Abel et al.
HAEMATOLOGICA (2016)
Genetics factors associated with myelodysplastic syndromes
Luciana Conci Macedo et al.
BLOOD CELLS MOLECULES AND DISEASES (2015)
The molecular basis and clinical significance of genetic mutations identified in myelodysplastic syndromes
Ling Zhang et al.
LEUKEMIA RESEARCH (2015)
Primary Myelodysplastic Syndromes: The Mayo Clinic Experience With 1000 Patients
Naseema Gangat et al.
MAYO CLINIC PROCEEDINGS (2015)
Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations
Allison H. West et al.
BONE MARROW NICHE, STEM CELLS, AND LEUKEMIA: IMPACT OF DRUGS, CHEMICALS, AND THE ENVIRONMENT (2014)
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia
Luca Malcovati et al.
BLOOD (2014)
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R
Matteo G. Della Porta et al.
BLOOD (2014)
Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell Transplantation
Rafael Bejar et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Application of the International Prognostic Scoring System-Revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia
C. Y. Ok et al.
LEUKEMIA (2014)
Validation of the revised International Prognostic Scoring System (IPSS-R) in patients with myelodysplastic syndrome: A multicenter study
Judith Neukirchen et al.
LEUKEMIA RESEARCH (2014)
Validation of the IPSS-R in lenalidomide-treated, lower-risk myelodysplastic syndrome patients with del(5q)
M. A. Sekeres et al.
BLOOD CANCER JOURNAL (2014)
Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes
Asmita Mishra et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Revised IPSS (IPSS-R) stratification and outcome of MDS patients treated with azacitidine
Massimo Breccia et al.
ANNALS OF HEMATOLOGY (2013)
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
Luca Malcovati et al.
BLOOD (2013)
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Elli Papaemmanuil et al.
BLOOD (2013)
Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better Than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional Database
Maria Teresa Voso et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Mutations affecting mRNAsplicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes
Frederik Damm et al.
BLOOD (2012)
The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experience
Mathilde Lamarque et al.
BLOOD (2012)
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
Hideki Makishima et al.
BLOOD (2012)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine
Raphael Itzykson et al.
BLOOD (2011)
Myelodysplastic syndromes with bone marrow fibrosis
Matteo Giovanni Della Porta et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
The utility of the Sysmex XE-2100 analyzer's NEUT-X and NEUT-Y parameters for detecting neutrophil dysplasia in myelodysplastic syndromes
J. R. Furundarena et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2010)
Clinical Relevance of Bone Marrow Fibrosis and CD34-Positive Cell Clusters in Primary Myelodysplastic Syndromes
Matteo Giovanni Della Porta et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome:: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
Emilio Paolo Alessandrino et al.
BLOOD (2008)
Marrow fibrosis predicts early fatal marrow failure in patients with myelodysplastic syndromes
G. Buesche et al.
LEUKEMIA (2008)
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes
Luca Malcovati et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Peripheral blood MDS score: A new flow cytometric tool for the diagnosis of myelodysplastic syndromes
S Cherian et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2005)
Myelodysplasia with fibrosis: a distinct entity?
DP Steensma et al.
LEUKEMIA RESEARCH (2001)
Share Paper
